Medicalsystem Biotechnology Co., Ltd (SHE:300439)

China flag China · Delayed Price · Currency is CNY
10.34
+0.16 (1.57%)
Mar 10, 2026, 2:55 PM CST
-8.33%
Market Cap 3.91B
Revenue (ttm) 1.47B
Net Income (ttm) 94.17M
Shares Out 384.32M
EPS (ttm) 0.24
PE Ratio 41.64
Forward PE n/a
Dividend 0.13 (1.32%)
Ex-Dividend Date Jun 23, 2025
Volume 3,193,800
Average Volume 3,171,636
Open 9.91
Previous Close 10.18
Day's Range 9.91 - 10.35
52-Week Range 9.40 - 12.67
Beta 0.28
RSI 50.50
Earnings Date Apr 29, 2026

About SHE:300439

Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT.It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly... [Read more]

Sector Healthcare
Founded 2003
Employees 2,104
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300439
Full Company Profile

Financial Performance

In 2024, SHE:300439's revenue was 1.74 billion, a decrease of -7.61% compared to the previous year's 1.89 billion. Earnings were 258.00 million, an increase of 0.56%.

Financial Statements

News

There is no news available yet.